Coronation Fund Managers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,205
Closed -$238K 79
2021
Q3
$238K Hold
2,205
0.01% 69
2021
Q2
$248K Sell
2,205
-739
-25% -$83.2K 0.01% 70
2021
Q1
$319K Hold
2,944
0.01% 63
2020
Q4
$315K Buy
+2,944
New +$283K 0.01% 66
2020
Q3
Sell
-77,985
Closed -$7.66M 68
2020
Q2
$7.66M Sell
77,985
-34,852
-31% -$3.07M 0.29% 39
2020
Q1
$8.6M Sell
112,837
-2,950
-3% -$251K 0.41% 34
2019
Q4
$10.3M Buy
115,787
+15,125
+15% +$1.26M 0.35% 47
2019
Q3
$7.62M Buy
100,662
+10,327
+11% +$708K 0.28% 53
2019
Q2
$6.57M Buy
+90,335
New +$7.1M 0.24% 57

Other funds holding ABBV

Coronation Fund Managers's ABBV Position: Q4 2021 in Review

Coronation Fund Managers sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 2,205 shares — an estimated $238K sold.

Coronation Fund Managers first reported a position in ABBV in Q2 2019 and held it in 9 quarters. The position peaked at $10.3M in Q4 2019. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • Coronation Fund Managers reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
  • Coronation Fund Managers sold 2,205 AbbVie shares in Q4 2021, an estimated $238K.
  • Coronation Fund Managers first reported a position in AbbVie in Q2 2019 and held it in 9 quarters.
  • Coronation Fund Managers's AbbVie position peaked at $10.3M in Q4 2019.
  • 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Coronation Fund Managers's 13F filing for Q4 2021, filed 14 Feb 2022.